NSF International Expands Health Sciences Group With Acquisition of Majority Interest in Amarex CRO
The transaction creates a single access point for medical device and pharma/biotech product developers seeking integrated, expert services throughout the entire product lifecycle.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.